Latest News and Press Releases

HUDDINGE, Sweden, Oct. 23, 2002 (PRIMEZONE) -- Tripep AB:- A new Board of Directors was elected at the extraordinary shareholders' meeting held on 17 September 2002. The new Board consistsof Rolf L....

HUDDINGE, Sweden, Aug. 29, 2002 (PRIMEZONE) -- Tripep AB (publ): -- Continued work on GPG and its metabolite has made it clear that the company currently has no candidate drug in the HIV...

HUDDINGE, Sweden, June 6, 2002 (PRIMEZONE) -- Tripep AB (publ) will subscribe for new shares corresponding to 30% of the share capital in Finnish biotech-company Ipsat Therapies Oy, with an option to...

HUDDINGE, Sweden, April 26, 2002 (PRIMEZONE) -- Tripep AB (publ): - A pharmacological pig study designed to determine the best administration form for GPG(R) will be launched...

HUDDINGE, Sweden, April 9, 2002 (PRIMEZONE) -- At today's Annual General Meeting of Tripep AB (publ), the President reported on the past year and on the development of Tripep's research projects. A...

HUDDINGE, Sweden, Jan. 25, 2002 (PRIMEZONE) -- Tripep AB (publ): -- New plan adopted, entailing three areas of operation for Tripep: -- the HIV-inhibiting pharmaceutical GPG(r), -- a...

STOCKHOLM, Sweden, Jan. 18, 2002 (PRIMEZONE) -- In order to free resources to be used for acquisitions of research companies and in licensing of projects in the clinical phase, Tripep has adopted a...